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Abstract
Background: Indonesia’s increase of acquired immunodeficiency syndrome (AIDS) cases is one of the 
fastest.  Mortality cases of AIDS also increase per year. Central nervous system (CNS) opportunistic infection 
is one of the most likely manifestations on advanced stage of Human immunodeficiency virus (HIV)/AIDS 
patients.  Common CNS opportunistic infections are toxoplasma infection and tuberculous meningitis (TBM). 
The study aimed to analyze the predictor of mortality in AIDS patients with CNS opportunistic infections.
Methods: This study reviewed 151 medical records from AIDS patients with CNS opportunistic infection 
admitted to the Department of Neurology, Dr. Hasan Sadikin General Hospital Bandung from 2007-2012. 
This study was conducted from April to November 2013. Patients’ clinical manifestations (seizure, headache, 
altered consciousness), laboratory examination (CD4+ level count) and treatment history (antiretroviral or 
ART and cotrimoxazole) were collected. Chi-square and logistic regression test were used to determine the mortality predictor in patients.
Results: Mortality rate was 37.7%. Clinical manifestations from patients were seizure 29.8%, altered 
consciousness 66.2%, and headache 88.7%. Patients had cotrimoxazole treatment 44.4% and 38.4% 
patients had ART. CD4+ level count data from 86 patients were obtained, 94% had CD4+ level count ≤200. 
Bivariate analysis showed altered consciousness had significant mortality predictor (Odd ratio (OR): 29.944; 
95% Confidence interval (CI) 6.9–129.945; p<0,0). Multivariate analysis showed ART had highest predictive 
mortality value (OR: 2.968; 95% CI 1.236–7.126; p=0.015).
Conclusions: Altered consciousness and no antiretroviral treatment are mortality predictors in AIDS 
patients with CNS opportunistic infections. [AMJ.2016;3(4):577–82]
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Introduction
Human Immunodificiency Virus (HIV)/
Acquired immunodeficiency syndrome (AIDS) 
is one of the few diseases in which complete treatment is still elusive although prevention and treatment to control the virus have been 
well established for decades.1 In the last 30 
years, data from the World Health Organization 
(WHO) and Joint United Nations Programme 
on HIV/AIDS (UNAIDS) showed that HIV infection caused 25 million deaths around 
the world. Not like any other countries whose 
access to antriretroviral (ART) treatment 
have  reduced the number of AIDS related to 
death cases, reports from WHO and UNAIDS 
database, in Indonesia from 2006–2009 was 
recorded  an increase in AIDS related to death 
as much as 3 times along with more than 2 
times increase in new HIV infection cases from 
2010 to 2011.
With the advanced of science, it was known 
that the two main targets of HIV infection are the limphoid system and central nervous 
system (CNS).2,3 Infection of HIV markedly 
affected immune system was shown with 
immunodeficiency and level of CD4+ T cell, 
which made someone prone to opportunistic infection, neoplasm, and many other clinical conditions.2 From numerous earlier research 
in developing countries, the main cause of CNS 
impairment among HIV/AIDS patients were 
CNS opportunistic infections.4
Severe immunodeficiency in a late phase 
of HIV infection with high virus load both on 
systemic and CNS has a positive correlation 
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with the likelihood of CNS opportunistic 
infection. Environment and access to ART become important factors to the variation 
of CNS opportunistic infection between developed and developing countries.5 
The common CNS opportunistic infections 
in HIV/AIDS patients are toxoplasma 
infection, tuberculous meningitis (TBM), cryptococcus infection, progressive multifocal 
leukoencelopathy (PML) and primary CNS lymphoma.2,6 The risk of CNS opportunistic infection is different according to patient’s 
CD4+ T cell level;  patients with CD4+ T cell 
level 200– 500/µL have risk being infected by 
tuberculous meningitis, patients with CD4+ 
T cell level <200/µL have risk being infected 
by toxoplasmosis encephalitis, cryptococcus 
meningitis, cytomegalovirus (CMV) infection, 
primary lymphoma CNS, and PML.5 Almost all 
CNS opportunistic infections originate from 
activated latent pathogen, except PML that 
could be caused by direct HIV-1 virus infection.5 
Most of all CNS opportunistic infections do not 
have specific symptoms like fever or lethargic. 
Symptoms which usually arise are headache, 
seizure, altered consciousness, altered mental 
function, focal deficit and cranial neuropathy.5
A study  in Bangkok Thailand5, showed 
that mortality rate of HIV/AIDS patients 
with CNS opportunistic infections was 14.9% 
and in Nigeria7 and Ethiopia4 showed high 
case-fatality up to 45%. There were several 
predictors of mortality in HIV/AIDS cases. The 
study in Ethiophia4, discovered  that the area of the patients’ residency, altered consciousness, 
and seizure were predictors of mortality in 
HIV/AIDS cases.Based on these evidences, the objective 
of this study was to analyze the predictors 
of mortality in  Acquired Immunodeficiency 
Syndrome patients with central nervous 
system opportunistic infections in Bandung, Indonesia.
Methods
A retrospective cross-sectional study was conducted at Dr. Hasan Sadikin General 
Hospital, Bandung, Indonesia from April to 
November 2013. Data were obtained from 
medical records of AIDS patients admitted 
to the Neurology Department of Dr. Hasan 
Sadikin General Hospital from January 
2007–December 2012. The inclusion criteria 
were medical records of AIDS patients with 
CNS opportunistic infection(s) consisting of 
information of altered consciousness, seizure, 
headache, CD4+ level count, ART treatment, 
cotrimoxazole treatment and the outcome 
of the treatment. The exclusion criteria were imcomplete information in the patient’s medical records and unclear patient’s cause of death. 
From 2007 to 2012, there were 153 cases of 
AIDS with CNS opportunistic infections  from 
342 cases of HIV/AIDS, but only 151 cases  met the inclusion criteria.
The collected data were analyzed 
statistically using the Chi-square test for bivariate analysis and logistic regression 
for multivariate analysis with p value <0.05 
and 95% confidence interval as statistical 
significance. The Ethical approval for this 
study was obtained from the Health Research 
Ethics Committee of Faculty of Medicine of Universits Padjadjaran/Dr. Hasan Sadikin General Hospital.
Results
This study discovered that male had 
Table 1 Characteristics of  Patients 
Variable n=151
Sex    Female 42 (28.1%)    Male 109 (71.9%)
Age (years old)
   <30 63 (41.7%)
   ≥30 88 (58.3%)   Mean 30.8  Range 20¬–54Mortality rate 57 (37.7%)
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higher percentage of AIDS cases with CNS opportunistic infections compared to  female. Morover, those cases occurred mostly to young 
people although the age range was wide. From 
all the cases,  mortality was still high (Table 1). 
In terms of  CNS opportunistic infections, most 
of the patients (106 cases)  had only 1 infection. 
On the other hand, there were patients with 
multiple infections. One of the patients had 
4 infections, 4 patients had 3 infections, and 
40 patients had 2 infections. (Table 2). The 
most infection occured in those patients was 
cerebral toxoplasmosis 93 (61.6%). Other 
infections occured were TBM, followed by tuberculoma,  cryptococcus meningitis and 
CMV infection (39.1%,  20.0%, 11.3%, 2.0%, 
respectively) (Table 3).
There were 86 recorded data for CD4+ level 
count: 81 patients (94,20%) had CD4+ level 
count ≤200 and 5 patients (5,80%) had CD4+ 
level count >200 (Table 3).
Furthermore, there was 29.8% patients 
with seizure; 66.2% patients with altered 
consciousness; 88.7% patients with headache; 
44.4% patients with cotrimoxazole treatment; 
and 38.4% patients with antiretroviral 
treatment (Table 4). 
The highest case of fatality rateswas 
tuberculoma (60%), followed by cryptococcus 
meningitis (58.8%), TBM (47.5%), cerebral 
toxoplasmosis (35.5%), and CMV infection 
(33.3%) respectively (Table 4).
The bivariate statistical analysis was 
performed to determine which variables 
werecorrelated to mortality. This study 
discovered that altered consciousness was 
the predictor of  mortality AIDS patients with 
CNS opportunistic infection. Other variables, 
such as seizure, headache, CD4+ level count, 
cotrimoxazole treatment were not predictors 
of mortality in these cases (p value ≥ 0.05. 
Although no ART treatment was significantly 
related to predictor of mortality in AIDS 
patients with CNS opportunistic infections, the 
OR was below 1  (Table 5).Moreover, the logistic regression analysis 
was performed to determine which variable 
was the strongest predictor among the 
variables. The logistic regression analysis was 
performed for five variables (seizure, altered 
consciousness, headache, cotrimoxazole and 
ART). The variable CD4+ level count was not included into the analysis because the 
number of  medical records that had the CD4+ 
level count information was only 86 medical records.
The study showed that no treatment by ART 
(OR=2.968; 95% CI 1.236–7.126; p=0.015) 
was predictor for mortality AIDS patient with 
CNS opportunistic infection. Patients who 
Table 2 Distribution of CNS Opportunistic Infections
CNS opportunistic infections Total (n)
Cerebral toxoplasmosis, TBM, Criptococcus meningitis, Tuberculoma 1
Cerebral toxoplasmosis, TBM, Tuberculoma 1
Cerebral toxoplasmosis, Tuberculoma 19
Cerebral toxoplasmosis, Criptococcus meningitis, Tuberculoma 1
Cerebral toxoplasmosis, TBM, Criptococcus meningitis 1
Cerebral toxoplasmosis, Criptococcus meningitis 2
Cerebral toxoplasmosis, TBM, CMV infection 1
Cerebral toxoplasmosis, TBM 8
Cerebral toxoplasmosis, CMV infection 2
Cerebral toxoplasmosis 57
TBM, Criptococcus meningitis 6
TBM, Tuberculoma 2
TBM 39
Criptococcus meningitis 5
Criptococcus meningitis, Tuberculoma, 1
Tuberculoma 5
Note: TBM= Tuberculous meningitis; CMV=Cytomegalovirus
Althea Medical Journal. 2016;3(4)
580     AMJ December 2016
never had ART treatment had a mortality 
risk 2.968 times higher compared to patients 
who had ART treatment. Although altered 
consciousness was significantly related to 
predictor of mortality in AIDS patients with 
CNS opportunistic infections, the OR was 
below 1 (Table 6).
Discussion
This study discovered that the mortality 
of AIDS patients with CNS opportunistic 
infections was higher that the mortality in 
Bangkok Thailand.8 It was suspected that 
this condition occured because Thailand had 
a good treatment protocol regarding HIV patients and also the level of the people’s 
and the government’s awareness about this 
disease was higher compared to Indonesia. On the other hand,  the mortality rate in this study 
was lower compared to a study in Ethiopia, 
Africa4 as this region had higher HIV/AIDS cases prevalence compared to Indonesia. 
Besides, the sex distribution showed that male outnumbered female and the majority 
of patients were at young age (mean age 30.8 
years old). These findings were similar with several previous studies.4,7,9Interestingly, compared to a study in 
Thailand10 which stated that cryptococcal 
meningitis was the most frequent AIDS-related 
opportunistic infection; in this study, cerebral 
toxoplasmosis had the highest prevalence among other infections. Moreover, another study in Indonesia11 stated that cryptococcal 
meningitis was the most important CNS 
opportunistic infection. Cryptococcal 
meningitis arises on patients with very low 
CD4+ level count and usually patients died 
before they are diagnosed for the disease. HIV 
patients often seek care only when they are 
already on their late stage and low awareness 
to follow up especially the measurement 
of their CD4+ level count. The percentage 
of cerebral toxoplasmosis in this study was 
higher compared with a study in Ethiopia4 
(36.6%) and a study in India12 (8.8%). This may 
be caused by the difference in the prophylaxis 
treatment protocol especially cotrimoxazole in Indonesia and other countries. 
Table 4 Clinical Manifestation, Laboratory Findings and Treatment per Infection 
CNS Opportunistic Infections Death Altered 
Conciousness
Headache Cotrimoxazole ART 
TBM (59)  28 (47.5%)  44 (74.6%) 52 (88.1%) 25 (42.4%) 16 (27.1%)
Cryptococcus Meningitis (17) 10 (58.8%) 12 (70.6%)  17 (100%) 7 (41.2%)  8 (47.1%)
Cerebral Toxoplasmosis (93) 33 (35.5%) 62 (66.7%) 81 (87.1%) 44 (47.3%) 39 (41.9%)
Tuberculoma (30) 18 (60.0%) 20 (66.7%) 26 (86.7%)  15 (50.0%) 8 (26.7%)
CMV (3) 1 (33.3%) 1 (33.3%)  2 (66.7%) 1 (33.3%) 2 (66.7%)
Table 3 Demographic and Laboratory Findings per Infection
CNS Opportunistic Infections Age (years old) Sex CD4+ level
TBM(59) <30: 29 (49.2%) Male : 37 (62.7%) ≤200 : 28 (93.3%)
≥30 : 30 (50.8%) Female :  22 (37.3%) >200 :  2 (6.7%)
Cryptococcus Meningitis (17) <30: 7 (41.2%) Male : 13 (76.5%) ≤200 : 17 (100%)
≥30 : 10 (58.8%) Female : 4 (23.5%) >200 : 0 (0%)
Cerebral Toxoplasmosis (93) <30: 36 (38.7%) Male :  69 (74.2%) ≤200 : 53 (94.6%)
Female : 24 (25.8%) >200 : 3 (5.4%)
Tuberculoma (30) <30: 11 (36.7%) Male : 18 (60.0%) ≤200 :  13 (92.9%)
≥30 : 19 (63.3%) Female : 12 (40.0%) >200 :  1 (7.1%)
CMV (3) <30: 0 (0%) Male :  2 (66.7%) ≤200 : 3 (100%) ≥30 : 3 (100%) Female : 1 (33.3%) >200 : -
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Table 5 Bivariate (Chi-square) Analysis
Risk Factor  Total (57) OR  (95% CI) p 
Seizure 20  1.492 (0.733–3.037) 0.269
Altered Consciousness 55  29.944(6,900–129.945) 0.0Headache 51  1.127 (0.393–3.232) 0.825
CD4+level count (28) >200 2 1 0.714
≤200 26 1.410(0.222–8.960)
Cotrimoxazole treatment 26  1.084(0.559–2.101) 0.811
ART treatment  45  0.278(0.131–0.592) 0.001
Note : OR = Odd ratio ; CI = Confidence Interval; ART=Anti retrovirus
Other infections identified in this study 
were TBM, tuberculoma, cryptococcus 
meningitis and CMV infection that were similar 
with the findings of other studies4,12,13, except 
a study in The United States4 where TBM and 
bacterial meningitis were rarely found.4 This 
different result showed that environment and 
access to ART are important factors to CNS opportunistic infection variations.5 
In addition, headache was identified as the highest prevalence of clinical symptoms, 
followed by altered consciousness and seizure. 
These findings were similar with a study in 
Ethiopia4. 
From 86 patients, the majority (94,20%) 
had CD4+ level count ≤200 and only 5,80% 
had CD4+ level count >200, the result 
showed consistency with studies in Ethiopia and India.4,12 No patients with cryptococcus 
meningitis and CMV infections had CD4+ 
level count >200. This was in line with HIV-
associated opportunistic infections of the CNS literatur.5 
A total of  43.8% patients had a history of 
cotrimoxazole prophylaxis treatment or the 
treatment was given during admission. Out of 
57 mortality cases, 54.4% patients never had 
a cotrimoxazole treatment and it was higher 
compared to the study in Ethiopia4 (44.6%). 
Prior to this, early detection of HIV and early 
cotrimoxazole prophylaxis treatment as 
primary prophylaxis on HIV/AIDS patients may suggest a decrease in the prevalence cerebral 
toxoplasmosis and its mortality. Thirty seven 
point nine percent patients had ART treatment 
both before and after admission. Among the 
mortality cases, 78.9% patients had no ART 
treatment. This was much higher than the 
study in Ethiopia (46.1%). The data support Indonesia’s need for more effective prevention 
and detection of HIV infection as well as access 
to ART treatment to improve cases of AIDS related to death.5,11
The bivariate analysis result showed altered 
consciousness (OR=29.944; 95% CI 6.900–
129.945; p=0.0) as predictor and multivariate 
analysis showed ART (OR=2.968; 95% CI 
1.236–7.126; p=0.015) as predictor. The multivariate analysis calculated 5 variables,  to 
find which variable had the strongest relation 
to mortality cases. Our study showed altered 
consciousness was the predictor mortality 
dependently and ART treatment was the 
strongest predictor among all variables. The 
used of ART was a predictor mortality for AIDS 
patients with CNS opportunistic infection. 
Patients who never had ART treatment had 
more mortality risk than patients who had ART treatment. Decrease immune system markedly 
showed stage severity of the disease and make 
Table 6 Multivariate (Logistic Regression) Analysis 
Risk Factor Total (57) OR  (95% CI) p 
Seizure 20  1.228 (0.536–2.814) 0.628
Altered Consciousness 55  0.037 (0.008–0.163) 0.000Headache 51  0.661 (0.187–2.335) 0.661
Cotrimoxazole 26 0.718 (0.320–1.612) 0.422
ART 45 2.968 (1.236–7.126) 0.015
Note : OR = Odd ratio ; CI = Confidence Interval; ART=Anti retrovirus
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someone prone to opportunistic infection.2 
Antiretroviral treatment has functioned as disease severity suppressor to prevent the disease to an advanced stage and prevent opportunistic infections by increase immune system.2 In a future study, analysis about ART 
treatment and CD4+ level count could be added 
to investigate more exact about the correlation 
between ART treatment, CD4+ level count and disease severity and its outcome.  
This study had several limitations. Both 
cotrimoxazole and ART treatment were undifferentiated  before and after admission. 
The study did not investigate the time of HIV 
infection confirmed diagnosis and multiple 
CNS opportunistic infections that may affect patient’s outcome and mortality. Medical records data recording could be improved to provide more complete data, especially for 
laboratory examination result such as CD4+ count level to support a better research in the future. In conclusion, the majority of the patients 
have CD4+ count level ≤200 and only one-
third of the patients have ART treatment. 
Altered conciousness and no ART treatment are suspected to be the predictor of mortality 
in AIDS patients with CNS opportunistic 
infections.  The improvement of HIV screening, 
earlier primary prophylaxis treatment, access 
to ART and follow up of CD4+ count level will result into a better outcome.
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